Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation by Davalos, Dimitrios, Kyu Ryu, Jae, Merlini, Mario, Baeten, Kim M., Le Moan, Natacha, Petersen, Mark A., Deerinck, Thomas J., Smirnoff, Dimitri S., Bedard, Catherine, Hakozaki, Hiroyuki, Gonias Murray, Sara, Ling, Jennie B., Lassmann, Hans, Degen, Jay L., Ellisman, Mark H., Akassoglou, Katerina

Get full text

Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation by Davalos, Dimitrios, Kyu Ryu, Jae, Merlini, Mario, Baeten, Kim M., Le Moan, Natacha, Petersen, Mark A., Deerinck, Thomas J., Smirnoff, Dimitri S., Bedard, Catherine, Hakozaki, Hiroyuki, Gonias Murray, Sara, Ling, Jennie B., Lassmann, Hans, Degen, Jay L., Ellisman, Mark H., Akassoglou, Katerina

Get full text

Enhancing Patient Activation and Self-Management Activities in Patients With Type 2 Diabetes Using the US Department of Defense Mobile Health Care Environment: Feasibility Study by Gimbel, Ronald W, Rennert, Lior M, Crawford, Paul, Little, Jeanette R, Truong, Khoa, Williams, Joel E, Griffin, Sarah F, Shi, Lu, Chen, Liwei, Zhang, LingLing, Moss, Jennie B, Marshall, Robert C, Edwards, Karen W, Crawford, Kristy J, Hing, Marie, Schmeltz, Amanda, Lumsden, Brandon, Ashby, Morgan, Haas, Elizabeth, Palazzo, Kelly

Get full text

Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence by Nielsen, Suzanne, Lintzeris, Nicholas, Murnion, Bridin, Degenhardt, Louisa, Bruno, Raimondo, Haber, Paul, Johnson, Jennifer, Hardy, Mark, Ling, Stephen, Saddler, Craig, Dunlop, Adrian, Demirkol, Apo, Silsbury, Catherine, Phung, Nghi, Houseman, Jennie, Larance, Briony

Get full text

N-Acetylcysteine Treatment in Two Patients with Relapsed Thrombotic Thrombocytopenic Purpura Increased ADAMTS13 Activity, Free Thiol Concentration in Plasma, and Inhibited Platelet... by Chen, Junmei, Özpolat, Tahsin, Norby, Colette, Le, Jennie, Ling, Minhua, Cate, Shelby A, Chung, Dominic W, Fu, Xiaoyun, Konkle, Barbara, Lopez, Jose A.

Get full text

Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the fingernail by Drake, Lynn, Babel, Dennis, Stewart, Daniel M., Rich, Phoebe, Ling, Mark R., Breneman, Debra, Scher, Richard K., Martin, Ann G., Pariser, David M., Pariser, Robert J., Ellis, Charles N., Kang, Sewon, Katz, Harry Irving, McDonald, Charles J., Muglia, Jennie, Savin, Ronald C., Webster, Guy, Elewski, Boni E., Leyden, James J., Bucko, Alicia D., Tschen, Eduardo H., Hanifin, Jon M., Morman, Manuel R., Shupack, Jerome L., Levine, Norman, Lowe, Nicholas J., Bergfeld, Wilma F., Camisa, Charles, Feingold, David Stuart, Konnikov, Nellie, Odom, Richard B., Aly, Raza, Greer, Donald L.

Get full text

Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail by Ling, Mark R., Swinyer, Leonard J., Jarratt, Michael Taylor, Falo, Louis, Monroe, Eugene W., Tharp, Michael, Kalivas, James, Weinstein, Gerald D., Asarch, Richard G., Drake, Lynn, Martin, Ann G., Leyden, James J., Cook, Joel, Pariser, David M., Pariser, Robert, Thiers, Bruce H., Lebwohl, Mark G., Babel, Dennis, Stewart, Daniel M., Eaglstein, William H., Falanga, Vincent, Katz, H.Irving, Bergfeld, Wilma F., Hanifin, Jon M., Kang, Sewon, McDonald, Charles J., Muglia, Jennie, Goffe, Bernard S., Young, Marvin R.

Get full text